Johns Hopkins Alzheimer's Disease Research Center
约翰·霍普金斯大学阿尔茨海默病研究中心
基本信息
- 批准号:10374071
- 负责人:
- 金额:$ 318.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaBaltimoreBasic ScienceBehavioralBiological MarkersBiological ModelsBiostatistics CoreCancer Education Grant ProgramCancer Grant Supplements (P30)ClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesDataData AnalysesDevelopmentDiseaseEnrollmentEnvironmentEventFosteringFundingFunding AgencyFutureGoalsGrantGrowthHumanIndividualInstitutionIntramural Research ProgramJointsK-Series Research Career ProgramsLaboratoriesLeadershipLinkLongitudinal StudiesMentorshipMethodologyMethodsMindMolecularNational Institute on AgingNeurosciencesParticipantPatient CarePatientsPhasePilot ProjectsPlayProcessResearchResearch PersonnelResearch TrainingResourcesRoleSourceStrategic PlanningTalentsTherapeuticTissue BanksTissuesTrainingTraining SupportTranslatingUniversitiesWorkbrain tissuedata managementdesigneducation researcheducational atmospherehuman modelimprovedinnovationinsightinterestmeetingsneuropathologynext generationoutreachpre-clinicalprogramsrecruitresearch studysenior faculty
项目摘要
OVERALL – PROJECT SUMMARY/ ABSTRACT
The Johns Hopkins Alzheimer's Disease Research Center (JHADRC) is an integrated program of investigators
whose overarching goal is to improve understanding of the earliest phases of AD and to expand therapeutic
approaches. The overall scientific focus of the JHADRC is on the earliest stages of AD and related disorders in
humans and in model systems, through characterizing the earliest clinical and pathophysiological processes,
and by identifying cellular and molecular events that contribute to the abnormalities in model systems that
capture aspects of the human disorders. We also focus efforts on improving care of patients in the
symptomatic phases of disease. We have made substantial progress with these research goals during the
current funding cycle, supported by a P50 center grant, and propose to continue and expand this work in the
next funding cycle, through a P30 grant mechanism. The proposed Center consists of 6 Cores and one
component : (1) the Administrative Core (Core A), (2) the Clinical Core (Core B), (3) the Data Management and
Biostatistics Core (Core C), (4) the Neuropathology Core (Core D), (5) the Outreach, Recruitment and
Engagement Core (Core E), (6) the Biomarker Core (Core F) and (7) the Research Education Component
(REC). In this application we are also including funds for 3 Developmental Projects; we anticipate funding one
developmental project for 2 years and two developmental projects for 3 years each.
总体而言——项目概要/摘要
约翰·霍普金斯大学阿尔茨海默病研究中心 (JHADRC) 是一个由研究人员组成的综合项目
其总体目标是提高对 AD 早期阶段的了解并扩大治疗范围
接近。 JHADRC 的总体科学重点是 AD 和相关疾病的最早阶段
人类和模型系统中,通过表征最早的临床和病理生理过程,
并通过识别导致模型系统异常的细胞和分子事件
捕捉人类疾病的各个方面。我们还致力于改善患者的护理
疾病的症状阶段。在此期间,我们在这些研究目标方面取得了实质性进展
目前的资助周期,由 P50 中心拨款支持,并建议在
下一个资助周期,通过 P30 赠款机制。拟议的中心由 6 个核心和 1 个组成
组成部分:(1) 管理核心(核心 A)、(2) 临床核心(核心 B)、(3) 数据管理和
生物统计学核心(核心 C)、(4) 神经病理学核心(核心 D)、(5) 外展、招募和
参与核心(核心 E)、(6) 生物标记核心(核心 F)和 (7) 研究教育部分
(记录)。在此申请中,我们还包括 3 个开发项目的资金;我们预计资助其中一项
为期 2 年的发展项目和两个为期 3 年的发展项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARILYN S. ALBERT其他文献
MARILYN S. ALBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARILYN S. ALBERT', 18)}}的其他基金
Johns Hopkins Alzheimer's Disease Research Center
约翰霍普金斯大学阿尔茨海默病研究中心
- 批准号:
9921614 - 财政年份:2020
- 资助金额:
$ 318.24万 - 项目类别:
Johns Hopkins Alzheimer's Disease Research Center
约翰·霍普金斯大学阿尔茨海默病研究中心
- 批准号:
10591542 - 财政年份:2020
- 资助金额:
$ 318.24万 - 项目类别:
Development of MRI microvascular biomarkers in cognitive impairment and dementia
认知障碍和痴呆 MRI 微血管生物标志物的开发
- 批准号:
10001049 - 财政年份:2016
- 资助金额:
$ 318.24万 - 项目类别:
Development of MRI microvascular biomarkers in cognitive impairment and dementia
认知障碍和痴呆 MRI 微血管生物标志物的开发
- 批准号:
9770571 - 财政年份:2016
- 资助金额:
$ 318.24万 - 项目类别:
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
验证小血管对认知障碍和痴呆 (VCID) 生物标志物的贡献
- 批准号:
10611828 - 财政年份:2016
- 资助金额:
$ 318.24万 - 项目类别:
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
验证小血管对认知障碍和痴呆 (VCID) 生物标志物的贡献
- 批准号:
10368371 - 财政年份:2016
- 资助金额:
$ 318.24万 - 项目类别:
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
验证小血管对认知障碍和痴呆 (VCID) 生物标志物的贡献
- 批准号:
10888591 - 财政年份:2016
- 资助金额:
$ 318.24万 - 项目类别: